摘要
目的:探讨郑州市中老年人群心血管病(CVD)的发生风险。方法:2014年8月至2015年12月,从河南省郑州市6个社区筛选年龄40~74岁的常驻居民1993人。采用Framingham10年冠心病风险评分标准评估CVD的发生风险,采用logistic回归分析CVD的危险因素。结果:研究人群未来10 a CVD高发生风险的比例为40.6%,且男性高于女性(47.1%vs 37.6%,P<0.001)。Logistic回归分析显示,男性(B=0.524,OR=1.690,95%CI为1.377~2.073)、腹型肥胖(B=0.709,OR=2.031,95%CI为1.632~2.529)、TG(B=0.097,OR=1.102,95%CI为1.023~1.187)、尿白蛋白异常(B=0.670,OR=1.955,95%CI为1.486~2.572)均是CVD高发生风险的危险因素。结论:郑州市中老年人群未来10 a CVD的发生风险很高;加强对中老年人群尤其是男性,合并腹型肥胖、高血脂、高血压、糖尿病以及糖尿病高危人群的CVD一级预防和管理,可能有效降低CVD的发生风险。
Aim:To investigate the cardiovascular disease(CVD)risk among middle-aged and elderly population in Zhengzhou,Henan Province.Methods:A total of 1993 residents aged 40-74 years from 6 communities in Zhengzhou were recruited from August 2014 to December 2015.The Framingham risk score for coronary heart disease was used to predict the risk of CVD in the future 10 years.Logistic regression analysis was used to analyze risk factors of high CVD risk.Results:The total proportion of high CVD risk of the population in the future 10 years was 40.6%,and the proportion in males was significantly higher than that in females(47.1%vs 37.6%,P<0.001).The results of logistic regression analysis showed that males(B=0.524,OR=1.690,95%CI was 1.377-2.073),central obesity(B=0.709,OR=2.031,95%CI was 1.632-2.529),TG(B=0.097,OR=1.102,95%CI was 1.023-1.187),albuminuria(B=0.670,OR=1.955,95%CI was 1.486-2.572)were risk factors for high CVD risk.Conclusion:The proportion of CVD risk in the future 10 years in middle-aged and elderly population in Zhengzhou is high.Strengthening the primary prevention and management of CVD for middle-aged and elderly people,especially for males,those who are complicated with abdominal obesity,hyperlipidemia,hypertension,diabetes or with high risk for diabetes,may effectively reduce the incidence of CVD.
作者
王娇
马晓君
赵艳艳
郭丰
吴丽娜
马笑堃
陈珊珊
张太意
秦贵军
WANG Jiao;MA Xiaojun;ZHAO Yanyan;GUO Feng;WU Lina;MA Xiaokun;CHEN Shanshan;ZHANG Taiyi;QIN Guijun(Department of Endocrinology,the First Affiliated Hospital,Zhengzhou University,Zhengzhou 450052;Department of Endocrinology,the General Hospital of Jinshui District,Zhengzhou 450000)
出处
《郑州大学学报（医学版）》
CAS
北大核心
2021年第1期93-96,共4页
Journal of Zhengzhou University(Medical Sciences)
基金
国家自然科学基金项目(81500646)。
